LEXINGTON, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced the appointment of Laura Adams to its Board of Directors, effective immediately.
News
T2 Biosystems Announces Second Quarter 2021 Financial Results
LEXINGTON, Mass., Aug. 05, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced financial results for the three months ended June 30, 2021. Click here to view original post… […]
News
T2 Biosystems Announces Plans to Consolidate and Expand Facilities in Massachusetts
LEXINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, announced today plans to consolidate its existing facilities and expand into a newly leased facility in Billerica, Massachusetts. The Company will consolidate its existing operations in Lexington, MA and… Click here to view original post… […]
News
T2 Biosystems T2SARS-CoV-2™ Panel Detects Omicron Variant
LEXINGTON, Mass., Dec. 01, 2021 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens, today announced that its T2SARS-CoV-2™ Panel detects the Omicron COVID-19 variant (B.1.1.529). Click here to view original post… […]
